TMEM43 and arrhythmogenic right ventricular cardiomyopathy: Integrating the insights from our current investigation, these collective observations lead us to postulate that the mutation-induced reduction of TMEM43 expression prompts the activation of SREBPs, thereby leading to the enhanced adipocyte differentiation in ARVC.